Diabetology & metabolic syndrome · 2025
Effect of vitamin D supplementation on body composition, lipid profile, and glycemic indices in patients with obesity-associated metabolic syndrome: a systematic review and meta-analysis.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ge Lili, Gao Shi, Kia Najaf, Wang Yanzhong, Hua Liqun
Аннотация
BACKGROUND: Vitamin D deficiency is common among individuals with obesity and metabolic disorders. Evidence on its effect on metabolic markers remains inconclusive. This systematic review and meta-analysis aimed to evaluate the impact of vitamin D supplementation on lipid profile, glycemic control, and anthropometric indices.
METHODS: A comprehensive search of PubMed, Embase, Cochrane Library, Web of Science, and China Knowledge Network was conducted from inception to May 2024. Randomized controlled trials (RCTs) evaluating oral vitamin D supplementation in adults with overweight, obesity, or metabolic disorders were included. Weighted mean differences (WMDs) and 95% confidence intervals (CIs) were calculated using a random-effects model.
RESULTS: Twenty-five RCTs (30 arms) were included. Overall, vitamin D supplementation did not significantly affect triglycerides (TG), total cholesterol (TC), HDL-C, LDL-C, fasting plasma glucose (FPG), insulin, HOMA-IR, HbA1c, waist circumference (WC), or body weight (p < 0.05). Subgroup analyses showed significant effects in certain populations, such as increased HDL-C in individuals with diabetes and elevated LDL-C in younger adults and males. A significant reduction in BMI was observed after adjusting for publication bias (p < 0.05). Heterogeneity varied across outcomes, and risk of bias was generally low, although some studies had unclear reporting.
CONCLUSION: Vitamin D supplementation has limited effects on metabolic and anthropometric markers in adults with obesity or related metabolic disorders. Certain subgroups may benefit, warranting further targeted research.
METHODS: A comprehensive search of PubMed, Embase, Cochrane Library, Web of Science, and China Knowledge Network was conducted from inception to May 2024. Randomized controlled trials (RCTs) evaluating oral vitamin D supplementation in adults with overweight, obesity, or metabolic disorders were included. Weighted mean differences (WMDs) and 95% confidence intervals (CIs) were calculated using a random-effects model.
RESULTS: Twenty-five RCTs (30 arms) were included. Overall, vitamin D supplementation did not significantly affect triglycerides (TG), total cholesterol (TC), HDL-C, LDL-C, fasting plasma glucose (FPG), insulin, HOMA-IR, HbA1c, waist circumference (WC), or body weight (p < 0.05). Subgroup analyses showed significant effects in certain populations, such as increased HDL-C in individuals with diabetes and elevated LDL-C in younger adults and males. A significant reduction in BMI was observed after adjusting for publication bias (p < 0.05). Heterogeneity varied across outcomes, and risk of bias was generally low, although some studies had unclear reporting.
CONCLUSION: Vitamin D supplementation has limited effects on metabolic and anthropometric markers in adults with obesity or related metabolic disorders. Certain subgroups may benefit, warranting further targeted research.